Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 4:69:1607245.
doi: 10.3389/ijph.2024.1607245. eCollection 2024.

Trends in the Disease Burden and Risk Factors of Women's Cancers in China From 1990 to 2019

Wei Ning #  1   2 , Jinnan Liu #  1 , Yongbo Lu  1 , Bin Zhu  3 , Wei-Hong Zhang  2 , Ying Mao  1
Affiliations

Trends in the Disease Burden and Risk Factors of Women's Cancers in China From 1990 to 2019

Wei Ning et al. Int J Public Health. .

Abstract

Objectives: To examine age-specific trends and risk factors in the burden of women's cancers (WCs) in China from 1990 to 2019 to inform strategies.

Methods: Data were sourced from the Global Burden of Disease 2019 and World Population Prospects 2019. Time trends, age differences, and key factors for breast, cervical, and ovarian cancers (BC, CC, and OC) were analyzed based on age-standardized incidence rate (ASIR) and disability-adjusted life years (DALYs) rate.

Results: ASIRs for BC and CC increased over the study period, with a slower growth rate for CC after 2005, likely due to targeted HPV prevention. OC showed the highest ASIR and DALY increases, indicating a growing concern. Peak ASIR for BC and CC was in women aged 50-55, while OC showed a higher burden in women aged 70-79. Lower DALYs in women born after 1985 suggest improved healthcare access.

Conclusion: This study highlights significant trends in cancer burden among Chinese women, driven by age and reproductive health policies. Future efforts should enhance screening, health literacy, and age-targeted risk reduction for specific cancer types.

Keywords: China; breast cancer; cervical cancer; disease burden; ovarian cancer; risk factors; time trends.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they do not have any conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Research framework of this study (China, 1990–2019).
FIGURE 2
FIGURE 2
The age-period-cohort effect on the disease burden of three women’s cancers (Global Burden of Disease 2019 study, China and the world, 1990–2019). (A) Breast cancer. (B) Cervical cancer. (C) Ovarian cancer.
FIGURE 3
FIGURE 3
Trends of portion of disability-adjusted life years of women’s cancers attributable to risk factors (Global Burden of Disease 2019 study, China, 1990–2019). (A) Breast cancer. (B) Cervical cancer. (C) Ovarian cancer.
FIGURE 4
FIGURE 4
Portion of disability-adjusted life years of women’s cancers and risk factors attributable to disability-adjusted life years rate for age groups (Global Burden of Disease 2019 study, China, 2019). (A) Breast cancer. (B) Cervical cancer. (C) Ovarian cancer.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Ginsburg O, Bray F, Coleman M, Vanderpuye V, Eniu A, Kotha S, et al. The Global Burden of Women’s Cancers: A Grand Challenge in Global Health. Lancet (2016) 389. 10.1016/S0140-6736(16)31392-7 - DOI - PMC - PubMed
    1. Soerjomataram I, Lortet-Tieulent J, Parkin D, Ferlay J, Forman D, Bray F, et al. Global Burden of Cancer in 2008: A Systematic Analysis of Disability-Adjusted Life-Years in 12 World Regions. Lancet (2012) 380:1840–50. 10.1016/S0140-6736(12)60919-2 - DOI - PubMed
    1. Vos T, Barber R, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 301 Acute and Chronic Diseases and Injuries in 188 Countries, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. Lancet (2015) 386:743–800. 10.1016/S0140-6736(15)60692-4 - DOI - PMC - PubMed
    1. Saint-Ghislain MD, Levenbruck C, Bellesoeur A. Adverse Events of Targeted Therapies Approved for Women’s Cancers. Int J Women’s Dermatol (2021) 7:552–9. 10.1016/j.ijwd.2021.10.006 - DOI - PMC - PubMed
    1. Hasan F, Kranz S, Kennedy E, Guertin K, Shivappa N, Hebert J, et al. Diet Quality and Inflammatory Index Score Among Women’s Cancer Survivors: 1430. Med Sci Sport Exer (2021) 53:467–8. 10.1249/01.mss.0000764704.42497.9c - DOI - PMC - PubMed

LinkOut - more resources